Dotatate to Locate Coronary Plaques at High-risk of Myocardial Infarction

NCT05536960 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2024-02-14

No results posted yet for this study

Summary

To assess whether vulnerable coronary plaques have more uptake of 68Ga-Dotatate than non-vulnerable plaques.

Conditions

  • Atheroscleroses, Coronary

Interventions

OTHER

68Ga-Dotatate PET/CT

One 68Ga-Dotatate PET/CT to determine uptake of tracer in the arterial wall.

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-09
Primary Completion
2023-10-06
Completion
2023-10-06

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05536960 on ClinicalTrials.gov